Scrip
Supreme Court decision ends Mylan's UK levofloxacin challenge
17 November 2009
Ian Haydock
Please Login to read the full article.
17 November 2009
Ian Haydock
ian.haydock@informa.com
The UK Supreme Court has refused an application by Generics [UK] ( Mylan) to appeal against a finding by the UK Court of Appeal that the current supplementary protection certificate (SPC) for the antibacterial levofloxacin is valid.
The ruling ends Generics [UK]'s attempted challenge to...
Please Login to read the full article.
RELATED CONTENT
NEWS
- US court rules for Teva, claiming Merck & Co's Temodar patent is unenforceable
- French industry welcomes moves to boost the biopharmaceutical sector
- US Supreme Court refuses to weigh in on Apotex dispute over Plavix patent
- Watson CEO can query FTC on alleged effort to pressure deal with Apotex
FEATURES
- GE Healthcare aims to end unpredictability in early drug research
- Face-to-Face: Trophos - The French firm that hooked Actelion
EVENTS
01 January 1970
London, UK
01 January 1970
San Diego, US
01 January 1970
Providence, Rhode Island, and San Francisco, California
JOB OF THE WEEK
Promote your vacancy here
